Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Levonorgestrel vs. copper intrauterine devices for emergency contraception.N Engl J Med. 2021; 384: 335-344
The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. In: Higgins J, Green S, editors. Version 5.1.0 ed. West Sussex, England: John Wiley & Sons; 2011.
- Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use.Obstet Gynecol. 2013; 122: 1214-1221
- Continuation of copper-containing intrauterine devices at 6 months.Contraception. 2013; 87: 101-106
- Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users.Contraception. 2009; 80: 452-456
- Intrauterine contraception for adolescents aged 14-18 years: a multicenter randomized pilot study of levonorgestrel-releasing intrauterine system compared to the Copper T 380A.Contraception. 2010; 81: 123-127
- Acceptability of randomization to levonorgestrel versus copper intrauterine device among women requesting IUD insertion for contraception.Contraception. 2015; 92: 572-574
- Acceptability of intrauterine contraception among women living with human immunodeficiency virus: a randomised clinical trial.Eur J Contracept Reprod Health Care. 2016; 21: 220-226
- Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction.Am J Obstet Gynecol. 2015; 212: p50.e1-p50.e8
Publication stageIn Press Corrected Proof
ClinicalTrials.gov Identifier: NCT02175030